Press Release: May, 7th, 2009
Molegro releases Molegro Virtual Docker 3.2.
Aarhus, Denmark, May 7th, 2009 - Molegro is pleased to announce a new release of Molegro Virtual Docker, an integrated platform for computational drug design available for Windows, Linux, and Mac OS X. Molegro Virtual Docker offers high-quality protein-ligand docking based on novel optimization techniques combined with a user interface experience focusing on usability and productivity.
New features in version 3.2:
- Docking post-processing: it is now possible to perform energy minimization and optimize protein/ligand hydrogen bonds after docking.
- The Data Analyzer in MVD has been updated with a new chemistry module. The Data Analyzer is now able to show 2D depictions of molecules and docking results. Molecules may be depicted inside the spreadsheet cells or in a separate grid window. It is also possible to visualize the molecules directly in the 2D plotter and optionally cluster overlapping molecules.
- Ligand Energy Inspector has been improved with new options and more detailed energy overview.
- Cavities can now be merged and it is possible to restrict cavity detection to a specific region of the protein.
- More than 50 other improvements and bug fixes.
To download a trial version, please visit our company website at: http://www.molegro.com.
For more information contact:
Rene Thomsen, CEO
Molegro
C. F. Moellers Alle 8, Bldg. 1110
DK-8000 Aarhus
Denmark
E-mail: rt@molegro.com
Phone: (+45) 89 42 31 65
About Molegro
Molegro is a Danish company founded in 2005. Our company concentrates on developing high-performance drug discovery solutions leading to a faster drug-development process. Our goal is to provide scientifically superior products focusing on both state-of-the-art algorithms and an intuitive graphical user interface experience.